The Quarterly Provider Update provides a listing of Agency regulations and meeting notices. Non-regulatory changes to the Medicare and Medicaid programs, consisting of manual instructions, are also included in this listing.
| R804CP | January 2006 Update of the Hospital Outpatient Prospective Payment System (OPPS): Summary of Payment Policy Changes, OPPS PRICER Logic Changes, and Instructions for Updating the Outpatient Provider Specific File (OPSF) | 01/03/2006 | 01/01/2006 |
| R204OTN | Stage 1 Use and Editing of National Provider Identifier Numbers Received in Electronic Data Interchange Transactions, via Direct Data Entry Screens, or on Paper Claim Forms | 01/03/2006 | 01/01/2006 |
| R856CP | January 2006 Quarterly Average Sales Price (ASP) Medicare Part B Drug Pricing File, Effective January 1, 2006, and Revisions to April 2005, July 2005, and October 2005 Quarterly ASP Medicare Part B Drug Pricing Files | 01/03/2006 | 01/01/2006 |
| R47NCD | Changes to the Covered Indications for Tumor Antigen by Immunoassay CA 125 to Add Primary Peritoneal Carcinoma | 01/03/2006 | 01/01/2006 |
| R47NCD | Changes to the Covered Indications for Tumor Antigen by Immunoassay CA 125 to Add Primary Peritoneal Carcinoma | 01/03/2006 | 01/01/2006 |
| R47NCD | Changes to the Covered Indications for Tumor Antigen by Immunoassay CA 125 to Add Primary Peritoneal Carcinoma | 01/03/2006 | 01/01/2006 |
| R47NCD | Changes to the Covered Indications for Tumor Antigen by Immunoassay CA 125 to Add Primary Peritoneal Carcinoma | 01/03/2006 | 01/01/2006 |
| R47NCD | Changes to the Covered Indications for Tumor Antigen by Immunoassay CA 125 to Add Primary Peritoneal Carcinoma | 01/03/2006 | 01/01/2006 |
| R47NCD | Changes to the Covered Indications for Tumor Antigen by Immunoassay CA 125 to Add Primary Peritoneal Carcinoma | 01/03/2006 | 01/01/2006 |
| R47NCD | Changes to the Covered Indications for Tumor Antigen by Immunoassay CA 125 to Add Primary Peritoneal Carcinoma | 01/03/2006 | 01/01/2006 |
Email
Print
